These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9723765)

  • 41. A systematic review of stimulus parameters for eliciting distortion product otoacoustic emissions from adult humans.
    Petersen L; Wilson WJ; Kathard H
    Int J Audiol; 2017 Jun; 56(6):382-391. PubMed ID: 28635500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of ear-canal standing waves on measurements of distortion-product otoacoustic emissions.
    Whitehead ML; Stagner BB; Lonsbury-Martin BL; Martin GK
    J Acoust Soc Am; 1995 Dec; 98(6):3200-14. PubMed ID: 8550945
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Test-retest repeatability of distortion product otoacoustic emissions.
    Wagner W; Heppelmann G; Vonthein R; Zenner HP
    Ear Hear; 2008 Jun; 29(3):378-91. PubMed ID: 18382378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dependence of distortion product emission amplitude on primary-tone stimulus levels during middle-ear pressure changes.
    Richter B; Hauser R; Löhle E
    Acta Otolaryngol; 1994 May; 114(3):278-84. PubMed ID: 8073861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimum primary tone level setting for measuring high amplitude DPOAEs in guinea pigs.
    Michaelis CE; Gehr DD; Deingruber K; Arnold W; Lamm K
    Hear Res; 2004 Mar; 189(1-2):58-62. PubMed ID: 14987752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cancellation level and phase of the (f2-f1) distortion product.
    Humes LE
    J Acoust Soc Am; 1985 Oct; 78(4):1245-51. PubMed ID: 4056218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical significance of probe-tone frequency ratio on distortion product otoacoustic emissions.
    Nielsen LH; Popelka GR; Rasmussen AN; Osterhammel PA
    Scand Audiol; 1993; 22(3):159-64. PubMed ID: 8210955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new method of measuring distortion product otoacoustic emissions using multiple tone pairs: study of human adults.
    Kim DO; Sun XM; Jung MD; Leonard G
    Ear Hear; 1997 Aug; 18(4):277-85. PubMed ID: 9288473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of acute noise effects using distortion product otoacoustic emissions.
    Delb W; Hoppe U; Liebel J; Iro H
    Scand Audiol; 1999; 28(2):67-76. PubMed ID: 10384893
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Growth of L(f2--f1) and L(2f1--f2) with input level: influence of f2/f1.
    Humes LE
    Hear Res; 1980 Mar; 2(2):115-22. PubMed ID: 7364667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transient-evoked and 2F1-F2 distortion product oto-acoustic emissions in dogs: preliminary findings.
    Sockalingam R; Filippich L; Sommerlad S; Murdoch B; Charles B
    Audiol Neurootol; 1998; 3(6):373-85. PubMed ID: 9732131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Locus of generation for the 2f1-f2 vs 2f2-f1 distortion-product otoacoustic emissions in normal-hearing humans revealed by suppression tuning, onset latencies, and amplitude correlations.
    Martin GK; Jassir D; Stagner BB; Whitehead ML; Lonsbury-Martin BL
    J Acoust Soc Am; 1998 Apr; 103(4):1957-71. PubMed ID: 9566319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Towards the preferred stimulus parameters for distortion product otoacoustic emissions in adults: A preliminary study.
    Petersen L; Wilson WJ; Kathard H
    S Afr J Commun Disord; 2018 Jul; 65(1):e1-e10. PubMed ID: 30035604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects of short-term tone exposure on DPOAEs].
    Shi Y; Jiang S; Gu R
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Feb; 32(1):41-4. PubMed ID: 10743127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evoked otoacoustic emissions in humans with normal hearing].
    Sliwińska-Kowalska M; Sułkowski WJ; Murowaniecki Z
    Otolaryngol Pol; 1995; 49(1):46-56. PubMed ID: 7644200
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of distortion product otoacoustic emissions in infants with a combined air and bone conduction stimulus.
    Lalos T; Dobrev I; Probst R; Röösli C
    Int J Pediatr Otorhinolaryngol; 2023 Aug; 171():111628. PubMed ID: 37329704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distortion product emissions in humans. I. Basic properties in normally hearing subjects.
    Lonsbury-Martin BL; Harris FP; Stagner BB; Hawkins MD; Martin GK
    Ann Otol Rhinol Laryngol Suppl; 1990 May; 147():3-14. PubMed ID: 2110797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interpretation of distortion product otoacoustic emission measurements. II. Estimating tuning characteristics using three stimulus tones.
    Mills DM
    J Acoust Soc Am; 1998 Jan; 103(1):507-23. PubMed ID: 9440336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of distortion product otoacoustic emission suppression as an estimate of response growth.
    Gorga MP; Neely ST; Dorn PA; Konrad-Martin D
    J Acoust Soc Am; 2002 Jan; 111(1 Pt 1):271-84. PubMed ID: 11831801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.